Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case-control analysis

Journal of Cystic Fibrosis

Volumn 14, Issue 6, 2015, Pages 741-747

  Goeminne, Pieter C ^a   Nawrot, Tim S ^b,c   De Boeck, Kris ^a   Nemery, Ben ^c   Dupont, Lieven J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cystic fibrosis; Pseudomonas aeruginosa; Water

Indexed keywords

SURFACE WATER;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MALE; PANCREAS INSUFFICIENCY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; WALKING; WATER SUPPLY; ADOLESCENT; CHILD; COMPLICATION; LAKE; MIDDLE AGED; POND; PSEUDOMONAS INFECTIONS; RISK FACTOR; RIVER; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; LAKES; MALE; MIDDLE AGED; PONDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS; RIVERS; YOUNG ADULT;

EID: 84946497714     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.04.004     Document Type: Article

References (39)

1. Döring G., Conway S.P., Heijerman H.G.M., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16(4):749-767.
2. BMR Belgisch Mucoviscidose Register RBM Registre Belge de la Mucoviscidose. Het Belgisch Mucoviscidose Register Beknopt Verslag 2011 2014, Scientific Institute of Public Health, [44 pp. Rapport D/2014/2505/34. https://www.wiv-isp.be/epidemio/epinl/index20.htm].
3. Kosorok M.R., Zeng L., West S.E., et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001, 32(4):277-287.
4. Emerson J., Rosenfeld M., McNamara S., Ramsey B., Gibson R.L. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002, 34(2):91-100.
5. Konstan M.W., Morgan W.J., Butler S.M., et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007, 151(2):134-139. 2.
6. Nixon G.M., Armstrong D.S., Carzino R., et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001, 138(5):699-704.
7. Henry R.L., Mellis C.M., Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992, 12(3):158-161.
8. Speert D.P., Campbell M.E. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J Hosp Infect 1987, 9(1):11-21.
9. Aaron S.D., Vandemheen K.L., Ramotar K., et al. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 2010, 304(19):2145-2153.
10. Armstrong D.S., Nixon G.M., Carzino R., et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002, 166(7):983-987.
11. O'Carroll M.R., Syrmis M.W., Wainwright C.E., et al. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 2004, 24(1):101-106.
12. Jones A.M., Govan J.R., Doherty C.J., et al. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax 2003, 58(6):525-527.
13. Panagea S., Winstanley C., Walshaw M.J., Ledson M.J., Hart C.A. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect 2005, 59(2):102-107.
14. Knibbs L.D., Johnson G.R., Kidd T.J., et al. Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. Thorax 2014, 69(8):740-745.
15. Cramer N., Wiehlmann L., Ciofu O., Tamm S., Hoiby N., Tummler B. Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis. PLoS ONE 2012, 7(11). [e50731].
16. Khan N.H., Ishii Y., Kimata-Kino N., et al. Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microb Ecol 2007, 53(2):173-186.
17. Selezska K., Kazmierczak M., Musken M., et al. Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure. Environ Microbiol 2012, 14(8):1952-1967.
18. Sanders D.B., Bittner R.C., Rosenfeld M., Redding G.J., Goss C.H. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol 2011, 46(4):393-400.
19. Goeminne P.C., Kicinski M., Vermeulen F., et al. Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest 2013, 143(4):946-954.
20. De Boeck K., Wilschanski M., Castellani C., et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006, 61(7):627-635.
21. Proesmans M., Vermeulen F., Boulanger L., Verhaegen J., De Boeck K. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis. J Cyst Fibros 2013, 12(1):29-34.
22. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2(1):29-34.
23. Proesmans M., Balinska-Miskiewicz W., Dupont L., et al. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006, 27(5):937-943.
24. Vlaamse Milieumaatschappij VMM ALMeC2. Luchtkwaliteit in het Vlaamse Gewest. Jaarverslag immissiemeetnetten 2012. 2014. Ref Type: Abstract. http://www.vmm.be/pub/luchtkwaliteit-in-het-vlaamse-gewest-jaarverslag-immissiemeetnetten-kalenderjaar-2012/luchtkwaliteit-in-het-vlaamse-gewest-jaarverslag-immissiemeetnetten-kalenderjaar-2012-1#page=15%20http://www.vmm.be/pub/luchtkwaliteit-in-het-vlaamse-gewest-jaarverslag-immissiemeetnetten-kalenderjaar-2012/luchtkwaliteit-in-het-vlaamse-gewest-jaarverslag-immissiemeetnetten-kalenderjaar-2012-1#page=15.
25. Hardalo C., Edberg S.C. Pseudomonas aeruginosa: assessment of risk from drinking water. Crit Rev Microbiol 1997, 23(1):47-75.
26. Sibley C.D., Grinwis M.E., Field T.R., et al. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS ONE 2011, 6(7). [e22702].
27. Blatny J.M., Reif B.A., Skogan G., et al. Tracking airborne Legionella and Legionella pneumophila at a biological treatment plant. Environ Sci Technol 2008, 42(19):7360-7367.
28. Nguyen T.M., Ilef D., Jarraud S., et al. A community-wide outbreak of legionnaires disease linked to industrial cooling towers-how far can contaminated aerosols spread?. J Infect Dis 2006, 193(1):102-111.
29. Clifton I.J., Fletcher L.A., Beggs C.B., Denton M., Peckham D.G. A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. BMC Microbiol 2008, 8:105.
30. Clifton I.J., Fletcher L.A., Beggs C.B., Denton M., Conway S.P., Peckham D.G. An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. J Cyst Fibros 2010, 9(1):64-68.
31. Maekawa K., Ito Y., Hirai T., et al. Environmental risk factors for pulmonary Mycobacterium avium-intracellulare complex disease. Chest 2011, 140(3):723-729.
32. Rosenfeld M., Emerson J., McNamara S., et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros 2012, 11(5):446-453.
33. Parad R.B., Gerard C.J., Zurakowski D., Nichols D.P., Pier G.B. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun 1999, 67(9):4744-4750.
34. Schaedel C., de Monestrol I., Hjelte L., et al. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002, 33(6):483-491.
35. Cakmak S., Mahmud M., Grgicak-Mannion A., Dales R.E. The influence of neighborhood traffic density on the respiratory health of elementary schoolchildren. Environ Int 2012, 39(1):128-132.
36. Gauderman W.J., Avol E., Gilliland F., et al. The effect of air pollution on lung development from 10 to 18years of age. N Engl J Med 2004, 351(11):1057-1067.
37. Gauderman W.J., Vora H., McConnell R., et al. Effect of exposure to traffic on lung development from 10 to 18years of age: a cohort study. Lancet 2007, 369(9561):571-577.
38. Collaco J.M., McGready J., Green D.M., et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS ONE 2011, 6(11). [e27784].
39. Pirnay J.P., Matthijs S., Colak H., et al. Global Pseudomonas aeruginosa diversity as reflected in a Belgian river. Environ Microbiol 2005, 7(7):969-980.